Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a dietetic model of non-alcoholic fatty liver disease
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://data.mendeley.com/datasets/bs4hshm249
下载链接
链接失效反馈官方服务：
资源简介：
Non-alcoholic steatosis (NAFLD) and steatohepatitis (NASH) are two highly prevalent human disorders for which therapy remains suboptimal. In the present study we have compared the effects of BAR502, a dual FXR/GPBAR1 ligand) alone or in combination with ursodeoxycholic acid (UDCA) in a model of NAFLD/NASH induced by feeding mice with a Western diet for 10 weeks.
创建时间：
2022-09-13
